Skip to main content
Investor Relations Contact Us Careers
Nasdaq: FEMY
News Item

Femasys Receives CE Mark Approval for Four of its Women’s Health Products Clearing the Path for the Company to Begin Commercialization Efforts in Europe

June 20, 2024

Femasys received CE Mark approval for four of its women’s health products, clearing the path to begin commercialization in Europe.

View source →
← Back to Media